Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein

Clinical trial NCT05746611 · COMPLETED

Trial details

NCT number: NCT05746611
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Latent Tuberculosis Infection

Start date: 2023-04-17
Primary completion: 2024-05-13
Enrollment: 7500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.